Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,991 | $41,674 | $57,727 | $71,305 |
| - Cash | $13,524 | $13,694 | $16,241 | $10,308 |
| + Debt | $31,697 | $30,283 | $30,248 | $24,245 |
| Enterprise Value | $53,164 | $58,263 | $71,734 | $85,242 |
| Revenue | $41,067 | $41,400 | $43,952 | $39,005 |
| % Growth | -0.8% | -5.8% | 12.7% | – |
| Gross Profit | $19,702 | $19,804 | $20,782 | $18,777 |
| % Margin | 48% | 47.8% | 47.3% | 48.1% |
| EBITDA | $8,603 | $5,559 | $7,874 | $8,814 |
| % Margin | 20.9% | 13.4% | 17.9% | 22.6% |
| Net Income | $2,770 | $2,386 | $3,731 | $4,729 |
| % Margin | 6.7% | 5.8% | 8.5% | 12.1% |
| EPS Diluted | 1.04 | 0.89 | 1.43 | 1.85 |
| % Growth | 16.9% | -37.8% | -22.7% | – |
| Operating Cash Flow | $4,477 | $3,414 | $4,218 | $3,949 |
| Capital Expenditures | -$4,410 | -$5,337 | -$5,889 | -$4,973 |
| Free Cash Flow | $67 | -$1,922 | -$1,671 | -$1,024 |